T
TELOGENIS
.ORG Research
  • About
  • Research Library
  • Telomere Academy
  • Encyclopedia
  • Advisory Board
  • Tools
  • Contact
Explore Research
Home / Telomere Academy

Telomere Academy

Structured, self-paced educational modules on the science of telomeres, cellular aging, and longevity. The Academy is currently in development. Module 1 is available as a sample; additional modules will be published as they are completed and reviewed.

1

What Are Telomeres?

Structure, composition, and discovery history of chromosome end-caps.

Start Module →
2

Cell Division

Mitosis, the cell cycle, and the end-replication problem.

Start Module →
3

Why Telomeres Shorten

Mechanisms of attrition: replication, oxidative stress, and inflammation.

Start Module →
4

Cellular Senescence

The irreversible arrest state, triggers, and SASP.

Start Module →
5

Telomerase

The enzyme complex, TERT and TERC, and regulation mechanisms.

Start Module →
6

Longevity Research

Current landscape of interventions being studied for healthy aging.

Start Module →
7

Future Therapies

Senolytics, gene therapy, and regenerative medicine approaches.

Start Module →
TELOGENIS

An independent scientific education platform dedicated to advancing public understanding of cellular aging, telomere biology, and longevity science.

Research

  • Research Library
  • White Papers
  • Research Database
  • News & Publications

Education

  • Telomere Academy
  • Longevity Encyclopedia
  • Tools & Calculators
  • About TELOGENIS

Legal

  • Privacy Policy
  • Terms of Use
  • Medical Disclaimer
  • Contact

Medical Disclaimer: The content on TELOGENIS.org is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Regulatory Notice: No statements on this website have been evaluated by the Food and Drug Administration. No products, compounds, or interventions discussed herein are intended to diagnose, treat, cure, or prevent any disease.

© 2026 TELOGENIS.org. All rights reserved.

Editorial Standards Funding Disclosure Commercial Platform →